Burning Rock Biotech Limited (BNR) Return on equity 2020–2025
Burning Rock Biotech Limited (BNR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-10.3%FY2025 · since FY2020: -16.8% → -10.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -10.3% | +49.3 pp |
| FY2024 | -59.7% | +25.4 pp |
| FY2023 | -85.1% | -1.2 pp |
| FY2022 | -83.8% | -40.7 pp |
| FY2021 | -43.2% | -26.4 pp |
| FY2020 | -16.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice